Chemo-Free Doublet in First-Line Boosts PFS in Triple-Negative Breast Cancer

(MedPage Today) — CHICAGO — Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line treatment significantly reduced the risk of progression or death in patients with PD-L1-positive…